Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis. Arch Ital Urol Androl [Internet]. 2015 Jul. 7 [cited 2026 May 22];87(2):121-9. Available from: https://www.pagepressjournals.org/aiua/article/view/aiua.2015.2.121